Pre-eclampsia surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{Sara.Zand}} | {{CMG}} {{AE}} {{Sara.Zand}} | ||
== Delivery == | == Delivery == | ||
[[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following: | [[Delivery]] is the mainstay of therapy for [[preeclampsia]] in the 37 weeks of [[gestation]] or occurrence any of the following:<ref>{{cite journal|title=Gestational Hypertension and Preeclampsia|journal=Obstetrics & Gynecology|volume=135|issue=6|year=2020|pages=e237–e260|issn=0029-7844|doi=10.1097/AOG.0000000000003891}}</ref> | ||
:*Repeated episodes of [[severe hypertension]] despite maintenance treatment with 3 classes of [[antihypertensive agents]] | :*Repeated episodes of [[severe hypertension]] despite maintenance treatment with 3 classes of [[antihypertensive agents]] | ||
:*Progressive [[thrombocytopenia]] | :*Progressive [[thrombocytopenia]] | ||
Revision as of 20:53, 12 October 2020
|
Pre-eclampsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pre-eclampsia surgery On the Web |
|
American Roentgen Ray Society Images of Pre-eclampsia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Delivery
Delivery is the mainstay of therapy for preeclampsia in the 37 weeks of gestation or occurrence any of the following:[1]
- Repeated episodes of severe hypertension despite maintenance treatment with 3 classes of antihypertensive agents
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features, such as severe intractable headache, repeated visual scotomata,convulsions
- Nonreassuring fetal status
References
- ↑ "Gestational Hypertension and Preeclampsia". Obstetrics & Gynecology. 135 (6): e237–e260. 2020. doi:10.1097/AOG.0000000000003891. ISSN 0029-7844.